Boosting host immune defenses to treat tuberculosis A study suggests a new approach that might help treat Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis: making people's cells better at killing Mtb by harnessing RNA sensors in our cells, which detect the RNA of invading pathogens. For the first time, researchers have shown that RNA sensing is important in inhibiting Mtb's growth once it gets inside cells.
How an AI solution can design new tuberculosis drug regimens With a shortage of new tuberculosis drugs in the pipeline, a software tool can predict how current drugs--including unlikely candidates -- can be combined in new ways to create more effective treatments.
Study shows non-TB lung infections rising; more in women and older people Each year, more and more people are getting mycobacterial lung infections, and the total number living with such diseases is going up, according to a new study published in the journal Annals of the American Thoracic Society. Those at greatest risk are people above the age of 65 years and the elderly.
